相关实验视频

Updated: Jan 12, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

细菌纳米颗粒作为膀癌免疫治疗BCG的有效和安全替代品

Marine Colson¹, Arthur Aubry², Nicolas Gaide³

¹IRSD, Université de Toulouse, INSERM, INRAE, ENVT, Toulouse, France.

Cancer gene therapy

|October 31, 2025

概括

细菌细胞外囊泡 (bEVs) 是一种新的膀癌治疗方法,在瘤回归和免疫激活方面表现优于Bacillus Calmette-Guérin (BCG). 这种纳米级生物疗法为膀癌患者提供了潜在的更安全,更有效的治疗选择.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
纳米医学是一种纳米医学.

背景情况:

膀癌是一种常见的恶性瘤,通常用Bacillus Calmette-Guérin (BCG) 治疗.
BCG疗法具有可变的疗效和显著的副作用,需要替代治疗.
细菌细胞外囊泡 (bEVs) 是一种新的纳米生物疗法方法.

研究的目的:

评估从大肠杆菌 (Escherichia coli) 产生的静脉bEVs作为治疗非肌肉侵入性膀癌的疗效.
为了将bEVs的抗瘤作用与当前的黄金标准进行比较,BCG.
研究bEVs治疗作用背后的免疫机制.

主要方法:

采用了膀癌的正位素合成性大鼠模型,使用 luciferase 标记的瘤细胞.
对bEVs的静脉注射与BCG治疗进行了比较.
评估了瘤生长抑制,回归率和局部免疫反应 (T细胞透,淋巴结合物).

主要成果:

与BCG相比,静脉内bEVs显著抑制了瘤生长.
bEVs实现了优异的瘤回归,60%的完整清除与BCG的20%相比.
bEVs诱导了显著的局部免疫激活,包括T细胞透,这与瘤大小的减少相关.
在bEVs治疗时没有观察到死亡率或全身毒性.

结论:

与BCG相比,bEVs在膀癌治疗中表现出更高的疗效和更好的安全性.
部分情况下,bEVs的抗瘤作用是由强大的抗瘤免疫反应的诱导介导的.
这项研究强调了细菌细胞外囊泡的转化潜力,作为治疗膀癌的新纳米生物疗法.

更多相关视频

Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model

Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model

Published on: May 29, 2015

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

相关概念视频

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.